Construction of a Full Transcription Map of Human Papillomavirus Type 18 during Productive Viral Infection

ABSTRACT Human papillomavirus type 18 (HPV18) is the second most common oncogenic HPV genotype, responsible for ∼15% of cervical cancers worldwide. In this study, we constructed a full HPV18 transcription map using HPV18-infected raft tissues derived from primary human vaginal or foreskin keratinocytes. By using 5′ rapid amplification of cDNA ends (RACE), we mapped two HPV18 transcription start sites (TSS) for early transcripts at nucleotide (nt) 55 and nt 102 and the HPV18 late TSS frequently at nt 811, 765, or 829 within the E7 open reading frame (ORF) of the virus genome. HPV18 polyadenylation cleavage sites for early and late transcripts were mapped to nt 4270 and mainly to nt 7299 or 7307, respectively, by using 3′ RACE. Although all early transcripts were cleaved exclusively at a single cleavage site, HPV18 late transcripts displayed the heterogeneity of 3′ ends, with multiple minor cleavage sites for late RNA polyadenylation. HPV18 splice sites/splice junctions for both early and late transcripts were identified by 5′ RACE and primer walking techniques. Five 5′ splice sites (donor sites) and six 3′ splice sites (acceptor sites) that are highly conserved in other papillomaviruses were identified in the HPV18 genome. HPV18 L1 mRNA translates a L1 protein of 507 amino acids (aa), smaller than the 568 aa residues previously predicted. Collectively, a full HPV18 transcription map constructed from this report will lead us to further understand HPV18 gene expression and virus oncogenesis.

[1]  E. de Villiers,et al.  Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. , 2010, Virology.

[2]  Sylvie Doublié,et al.  Structural basis of UGUA recognition by the Nudix protein CFIm25 and implications for a regulatory role in mRNA 3′ processing , 2010, Proceedings of the National Academy of Sciences.

[3]  S. Vagner,et al.  Molecular mechanisms of eukaryotic pre-mRNA 3′ end processing regulation , 2009, Nucleic acids research.

[4]  M. Wong,et al.  Distribution of human papillomavirus types in cervical cancers in Hong Kong: Current situation and changes over the last decades , 2009, International journal of cancer.

[5]  Cary A Moody,et al.  Human Papillomaviruses Activate the ATM DNA Damage Pathway for Viral Genome Amplification upon Differentiation , 2009, PLoS pathogens.

[6]  J. Rader,et al.  Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6. , 2009, RNA.

[7]  J. Yates,et al.  Molecular architecture of the human pre-mRNA 3' processing complex. , 2009, Molecular cell.

[8]  L. Chow,et al.  Robust production and passaging of infectious HPV in squamous epithelium of primary human keratinocytes. , 2009, Genes & development.

[9]  Mikkel H. Schierup,et al.  RNA Exosome Depletion Reveals Transcription Upstream of Active Human Promoters , 2008, Science.

[10]  M. Guo,et al.  Control of the Papillomavirus Early-to-Late Switch by Differentially Expressed SRp20 , 2008, Journal of Virology.

[11]  L. Turek,et al.  The E8∧E2 Gene Product of Human Papillomavirus Type 16 Represses Early Transcription and Replication but Is Dispensable for Viral Plasmid Persistence in Keratinocytes , 2008, Journal of Virology.

[12]  L. Turek,et al.  Functional Mapping of the Human Papillomavirus Type 16 E1 Cistron , 2008, Journal of Virology.

[13]  S. Graham Papillomavirus 3' UTR regulatory elements. , 2008, Frontiers in bioscience : a journal and virtual library.

[14]  Hang Wang,et al.  Pre-Messenger RNA Cleavage Factor I (CFIm): Potential Role in Alternative Polyadenylation During Spermatogenesis1 , 2008, Biology of reproduction.

[15]  N. Sneige,et al.  Evaluation of a Commercialized In Situ Hybridization Assay for Detecting Human Papillomavirus DNA in Tissue Specimens from Patients with Cervical Intraepithelial Neoplasia and Cervical Carcinoma , 2007, Journal of Clinical Microbiology.

[16]  M. Klein,et al.  Crystal Structures of Four Types of Human Papillomavirus L1 Capsid Proteins , 2007, Journal of Biological Chemistry.

[17]  L. Tong,et al.  Polyadenylation factor CPSF-73 is the pre-mRNA 3'-end-processing endonuclease , 2006, Nature.

[18]  Zhi-Ming Zheng,et al.  Papillomavirus genome structure, expression, and post-transcriptional regulation. , 2006, Frontiers in bioscience : a journal and virtual library.

[19]  S. Franceschi,et al.  Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. , 2006, Vaccine.

[20]  F. Bray,et al.  Chapter 2: The burden of HPV-related cancers. , 2006, Vaccine.

[21]  Xavier Castellsagué,et al.  Chapter 1: HPV in the etiology of human cancer. , 2006, Vaccine.

[22]  Martin S. Taylor,et al.  Genome-wide analysis of mammalian promoter architecture and evolution , 2006, Nature Genetics.

[23]  J. Berkhof,et al.  Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands , 2005, British Journal of Cancer.

[24]  G. Gilmartin Eukaryotic mRNA 3' processing: a common means to different ends. , 2005, Genes & development.

[25]  S. Schwartz,et al.  A Downstream Polyadenylation Element in Human Papillomavirus Type 16 L2 Encodes Multiple GGG Motifs and Interacts with hnRNP H , 2005, Journal of Virology.

[26]  F. Smedts,et al.  HPV in situ hybridization: Impact of different protocols on the detection of integrated HPV , 2005, International journal of cancer.

[27]  Xiaomin Zhao,et al.  A 57-Nucleotide Upstream Early Polyadenylation Element in Human Papillomavirus Type 16 Interacts with hFip1, CstF-64, hnRNP C1/C2, and Polypyrimidine Tract Binding Protein , 2005, Journal of Virology.

[28]  J. Doorbar The papillomavirus life cycle. , 2005, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[29]  R. Berro,et al.  The HTLV-I Tax oncoprotein targets the retinoblastoma protein for proteasomal degradation , 2005, Oncogene.

[30]  Bin Tian,et al.  A large-scale analysis of mRNA polyadenylation of human and mouse genes , 2005, Nucleic acids research.

[31]  S. Graham,et al.  SF2/ASF Binds the Human Papillomavirus Type 16 Late RNA Control Element and Is Regulated during Differentiation of Virus-Infected Epithelial Cells , 2004, Journal of Virology.

[32]  Niseema D. Pachikara,et al.  U1A Inhibits Cleavage at the Immunoglobulin M Heavy-Chain Secretory Poly(A) Site by Binding between the Two Downstream GU-Rich Regions , 2004, Molecular and Cellular Biology.

[33]  Michelle S. Longworth,et al.  Pathogenesis of Human Papillomaviruses in Differentiating Epithelia , 2004, Microbiology and Molecular Biology Reviews.

[34]  Margaret E McLaughlin-Drubin,et al.  Propagation, infection, and neutralization of authentic HPV16 virus. , 2004, Virology.

[35]  D. Lowy,et al.  Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18. , 2004, Virology.

[36]  Zhi-Ming Zheng,et al.  Regulation of Alternative RNA Splicing by Exon Definition and Exon Sequences in Viral and Mammalian Gene Expression , 2004, Journal of Biomedical Science.

[37]  K. Ryan,et al.  Evidence that polyadenylation factor CPSF-73 is the mRNA 3' processing endonuclease. , 2004, RNA.

[38]  K. Yamanegi,et al.  Requirement of a 12-Base-Pair TATT-Containing Sequence and Viral Lytic DNA Replication in Activation of the Kaposi's Sarcoma-Associated Herpesvirus K8.1 Late Promoter , 2004, Journal of Virology.

[39]  W. Keller,et al.  Human Fip1 is a subunit of CPSF that binds to U‐rich RNA elements and stimulates poly(A) polymerase , 2004, The EMBO journal.

[40]  Kirk M Brown,et al.  A mechanism for the regulation of pre-mRNA 3' processing by human cleavage factor Im. , 2003, Molecular cell.

[41]  Lesley Morris,et al.  Organization of Human Papillomavirus Productive Cycle during Neoplastic Progression Provides a Basis for Selection of Diagnostic Markers , 2003, Journal of Virology.

[42]  T. Iftner,et al.  Identification of the E9^E2C cDNA and Functional Characterization of the Gene Product Reveal a New Repressor of Transcription and Replication in Cottontail Rabbit Papillomavirus , 2003, Journal of Virology.

[43]  S. Graham,et al.  Activity of the Human Papillomavirus Type 16 Late Negative Regulatory Element Is Partly due to Four Weak Consensus 5′ Splice Sites That Bind a U1 snRNP-Like Complex , 2003, Journal of Virology.

[44]  R. Stenberg,et al.  Characterization of the human cytomegalovirus UL75 (glycoprotein H) late gene promoter. , 2002, Virology.

[45]  J. T. Kadonaga,et al.  The RNA polymerase II core promoter: a key component in the regulation of gene expression. , 2002, Genes & development.

[46]  S. Graham,et al.  The Human Papillomavirus Type 31 Late 3′ Untranslated Region Contains a Complex Bipartite Negative Regulatory Element , 2002, Journal of Virology.

[47]  H. Bernard,et al.  Gene Expression of Genital Human Papillomaviruses and Considerations on Potential Antiviral Approaches , 2001, Antiviral therapy.

[48]  W. Keller,et al.  Human pre‐mRNA cleavage factor IIm contains homologs of yeast proteins and bridges two other cleavage factors , 2000, The EMBO journal.

[49]  J. Manley,et al.  The human papillomavirus type 16 negative regulatory RNA element interacts with three proteins that act at different posttranscriptional levels. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[50]  T. Iftner,et al.  The E8^E2C Protein, a Negative Regulator of Viral Transcription and Replication, Is Required for Extrachromosomal Maintenance of Human Papillomavirus Type 31 in Keratinocytes , 2000, Journal of Virology.

[51]  M. Ozbun,et al.  Two Novel Promoters in the Upstream Regulatory Region of Human Papillomavirus Type 31b Are Negatively Regulated by Epithelial Differentiation , 1999, Journal of Virology.

[52]  M. Remm,et al.  Human Papillomavirus Type 18 E1 Protein Is Translated from Polycistronic mRNA by a Discontinuous Scanning Mechanism , 1999, Journal of Virology.

[53]  M. Huynen,et al.  A pyrimidine-rich exonic splicing suppressor binds multiple RNA splicing factors and inhibits spliceosome assembly. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[54]  N. Cahill,et al.  A Functionally Distinct TATA Box Required for Late Progression through the Epstein-Barr Virus Life Cycle , 1998, Journal of Virology.

[55]  T. R. Broker,et al.  Transcription Factor YY1 Represses Cell-Free Replication from Human Papillomavirus Origins , 1998, Journal of Virology.

[56]  Craig Meyers,et al.  Temporal Usage of Multiple Promoters during the Life Cycle of Human Papillomavirus Type 31b , 1998, Journal of Virology.

[57]  E. Huang,et al.  Identification of Positive and Negative Regulatory Regions Involved in Regulating Expression of the Human Cytomegalovirus UL94 Late Promoter: Role of IE2-86 and Cellular p53 in Mediating Negative Regulatory Function , 1998, Journal of Virology.

[58]  M. Ozbun,et al.  Synthesis of infectious human papillomavirus type 18 in differentiating epithelium transfected with viral DNA , 1997, Journal of virology.

[59]  M. Ozbun,et al.  Characterization of late gene transcripts expressed during vegetative replication of human papillomavirus type 31b , 1997, Journal of virology.

[60]  M. Stanley,et al.  A cellular 65-kDa protein recognizes the negative regulatory element of human papillomavirus late mRNA. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[61]  T. Iftner,et al.  Identification of a differentiation-inducible promoter in the E7 open reading frame of human papillomavirus type 16 (HPV-16) in raft cultures of a new cell line containing high copy numbers of episomal HPV-16 DNA , 1996, Journal of virology.

[62]  H. B. Lim,et al.  Human papillomavirus type 31b late gene expression is regulated through protein kinase C-mediated changes in RNA processing , 1995, Journal of virology.

[63]  C. Baker,et al.  Sequences homologous to 5' splice sites are required for the inhibitory activity of papillomavirus late 3' untranslated regions , 1994, Molecular and cellular biology.

[64]  M. Remm,et al.  The E2 binding sites determine the efficiency of replication for the origin of human papillomavirus type 18. , 1992, Nucleic acids research.

[65]  M. Hummel,et al.  Differentiation-induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomes , 1992, Journal of Virology.

[66]  P. Howley,et al.  Transient replication of human papillomavirus DNAs , 1992, Journal of virology.

[67]  L. Sherman,et al.  Differential expression of HPV types 6 and 11 in condylomas and cervical preneoplastic lesions. , 1992, Virus research.

[68]  C. Meyers,et al.  Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. , 1992, Science.

[69]  T. R. Broker,et al.  Production of human papillomavirus and modulation of the infectious program in epithelial raft cultures. OFF. , 1992, Genes & development.

[70]  L. Sherman,et al.  Expression and splicing patterns of human papillomavirus type‐16 mrnas in pre‐cancerous lesions and carcinomas of the cervix, in human keratinocytes immortalized by HPV 16, and in cell lines established from cervical cancers , 1992, International journal of cancer.

[71]  T. R. Broker,et al.  An E1M--E2C fusion protein encoded by human papillomavirus type 11 is asequence-specific transcription repressor , 1991, Journal of virology.

[72]  M. Stanley,et al.  Detection of novel splicing patterns in a HPV16-containing keratinocyte cell line. , 1990, Virology.

[73]  P. Howley,et al.  Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters , 1990, Journal of virology.

[74]  T. R. Broker,et al.  Human papillomavirus type 1 produces redundant as well as polycistronic mRNAs in plantar warts , 1990, Journal of virology.

[75]  P. Howley,et al.  Phenotypic analysis of bovine papillomavirus type 1 E2 repressor mutants , 1990, Journal of virology.

[76]  L. Chow,et al.  Characterization of rare human papillomavirus type 11 mRNAs coding for regulatory and structural proteins, using the polymerase chain reaction. , 1989, Virology.

[77]  H. Prokoph,et al.  Oncogenic and nononcogenic human genital papillomaviruses generate the E7 mRNA by different mechanisms , 1989, Journal of virology.

[78]  Steven Wolinsky,et al.  Human papillomavirus types 6 and 11 mRNAs from genital condylomata acuminata , 1987, Journal of virology.

[79]  T. R. Broker,et al.  A human papilloma virus type 11 transcript encoding an E1--E4 protein. , 1987, Virology.

[80]  S. Cole,et al.  Nucleotide sequence and comparative analysis of the human papillomavirus type 18 genome. Phylogeny of papillomaviruses and repeated structure of the E6 and E7 gene products. , 1987, Journal of molecular biology.

[81]  M. Yaniv,et al.  Characterization of a transcriptional promoter of human papillomavirus 18 and modulation of its expression by simian virus 40 and adenovirus early antigens , 1987, Journal of virology.

[82]  A. Schneider-Gädicke,et al.  Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes. , 1986, The EMBO journal.

[83]  F. Wettstein,et al.  Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[84]  J. Brady,et al.  Site-specific base substitution and deletion mutations that enhance or suppress transcription of the SV40 major late RNA , 1982, Cell.

[85]  Margaret E McLaughlin-Drubin,et al.  Propagation of infectious, high-risk HPV in organotypic "raft" culture. , 2005, Methods in molecular medicine.

[86]  I. Mattaj,et al.  U1 snRNP inhibits pre-mRNA polyadenylation through a direct interaction between U1 70K and poly(A) polymerase. , 1998, Molecular cell.

[87]  M. Yaniv,et al.  Control of HPV 18 DNA replication by cellular and viral transcription factors. , 1995, Nucleic acids research.

[88]  P. Mounts,et al.  Heterogeneity in mRNA of human papillomavirus type-6 subtypes in respiratory tract lesions. , 1989, Virology.

[89]  F. Homa,et al.  A specific 15-bp TATA box promoter element is required for expression of a herpes simplex virus type 1 late gene. , 1988, Genes & development.